-
EP3812398
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3812398
| EP3812398 - ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.05.2022 Database last updated on 24.07.2024 | |
| Former | Request for examination was made Status updated on 31.12.2021 | ||
| Former | The application has been published Status updated on 26.03.2021 | ||
| Former | unknown Status updated on 25.06.2020 | Most recent event Tooltip | 20.05.2022 | Application deemed to be withdrawn | published on 22.06.2022 [2022/25] | Applicant(s) | For all designated states SANOFI 54 rue La Boétie 75008 Paris / FR | [2021/17] | Inventor(s) | 01 /
ALBRECHT, Jana Sanofi-Aventis Deutschland GmbH Patent Department 65926 Frankfurt / DE | 02 /
BARRIERE, Cédric Sanofi Patent Department 54 rue La Boétie 75008 Paris / FR | 03 /
BEIL, Christian Sanofi-Aventis Deutschland GmbH Patent Department 65926 Frankfurt / DE | 04 /
BENINGA, Jochen Sanofi-Aventis Deutschland GmbH Patent Department 65926 Frankfurt / DE | 05 /
CARREZ, Chantal c/o Sanofi Patent Department 54 rue La Boëtie F-75008 Paris / FR | 06 /
GUERIF, Stéphane Sanofi Patent Department 54 rue la Boétie 75008 Paris / FR | 07 /
KROLL, Katja Sanofi-Aventis Deutschland GmbH Patent Department 65926 Frankfurt / DE | 08 /
LANGE, Christian c/o Sanofi-aventis Deutschland GmbH Industriepark Hoechst, Building K801 D-65926 Frankfurt / DE | 09 /
LEMOINE, Cendrine Sanofi Patent Department 65926 Frankfurt / DE | 10 /
LEUSCHNER, Wulf-Dirk Sanofi-Aventis Deutschland GmbH Patent Department 65926 Frankfurt / DE | 11 /
RAO, Ercole c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE | 12 /
SCHNEIDER, Marion Sanofi-Aventis Deutschland GmbH Patent Department 65926 Frankfurt / DE | 13 /
WETZEL, Marie-Cécile Sanofi-Aventis Deutschland GmbH Patent Department 65926 Frankfurt / DE | 14 /
WONEROW, Peter Sanofi-Aventis Deutschland GmbH Patent Department 65926 Frankfurt / DE | [2021/17] | Representative(s) | Lavoix 2, place d'Estienne d'Orves 75441 Paris Cedex 09 / FR | [2021/17] | Application number, filing date | 20170198.4 | 22.01.2016 | [2021/17] | Priority number, date | EP20150305077 | 23.01.2015 Original published format: EP 15305077 | [2021/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP3812398 | Date: | 28.04.2021 | Language: | EN | [2021/17] | Type: | A3 Search report | No.: | EP3812398 | Date: | 21.07.2021 | Language: | EN | [2021/29] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.06.2021 | Classification | IPC: | C07K16/28, A61K39/00, A61P35/00, A61P35/02 | [2021/17] | CPC: |
C07K16/2866 (EP,CN,IL,US);
C07K16/2809 (EP,CN,IL,US);
A61P35/00 (EP,CN,IL);
A61P35/02 (EP,CN,IL);
C07K16/30 (IL,US);
G01N33/57492 (IL,US);
A61K2039/505 (EP,CN,IL,US);
C07K2317/21 (IL,US);
C07K2317/24 (IL,US);
C07K2317/31 (EP,CN,IL,US);
C07K2317/33 (EP,CN,IL,US);
C07K2317/52 (IL,US);
C07K2317/55 (IL,US);
C07K2317/56 (IL,US);
C07K2317/565 (IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/05] |
| Former [2021/17] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | ANTI-CD3-ANTIKÖRPER, ANTI-CD123-ANTIKÖRPER UND BISPEZIFISCHE, SPEZIFISCH AN CD3 UND/ODER CD123 BINDENDE ANTIKÖRPER | [2021/17] | English: | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 | [2021/17] | French: | ANTICORPS ANTI-CD3, ANTICORPS ANTI-CD123 ET ANTICORPS BISPÉCIFIQUES SE LIANT SPÉCIFIQUEMENT À CD3 ET/OU CD123 | [2021/17] | Examination procedure | deleted | Deletion: Application deemed to be withdrawn, date of legal effect [2021/17] | 23.12.2021 | Examination requested [2022/05] | 23.12.2021 | Date on which the examining division has become responsible | 22.01.2022 | Application deemed to be withdrawn, date of legal effect [2022/25] | 09.02.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2022/25] | Parent application(s) Tooltip | EP16701353.1 / EP3247725 | Divisional application(s) | EP22152787.2 | Request for further processing for: | The application is deemed to be withdrawn due to non-payment of the search fee | 06.08.2020 | Request for further processing filed | 06.08.2020 | Full payment received (date of receipt of payment) Request granted | 31.08.2020 | Decision despatched | Fees paid | Renewal fee | 17.04.2020 | Renewal fee patent year 03 | 17.04.2020 | Renewal fee patent year 04 | 17.04.2020 | Renewal fee patent year 05 | 13.01.2021 | Renewal fee patent year 06 | 16.12.2021 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2008119567 (MICROMET AG [DE], et al); | [A]WO2011109588 (HEALTH RESEARCH INC [US], et al); | [A]WO2011156860 (CSL LTD [AU], et al); | [A]WO2012021934 (CSL LTD [AU], et al); | [XDY]WO2012135345 (SANOFI SA [FR], et al); | [YD]WO2013173820 (SCOTT & WHITE HEALTHCARE [US]); | [A]WO2014129270 (UNIV KYOTO [JP], et al); | [A]WO2014138805 (CSL LTD [AU]); | [XY]WO2014164534 (GENZYME CORP [US]); | [Y]EP2789630 (ENGMAB AG [CH]); | [AP]EP2839842 (MACROGENICS INC [US]); | by applicant | US4179337 | US4301144 | US4361549 | EP0125023 | US4496689 | EP0173494 | US4640835 | WO8702671 | US4670417 | WO8705330 | EP0239400 | US4791192 | US4816567 | US4861719 | WO9109967 | EP0519596 | US5202238 | US5204244 | US5225539 | US5278056 | EP0592106 | WO9419478 | WO9514785 | WO9602576 | US5500362 | US5530101 | WO9622378 | US5565332 | US5585089 | WO9710354 | US5731168 | US5821337 | WO9845322 | WO9852975 | US5859205 | US5882877 | US5885573 | US5929212 | US5955358 | WO9954440 | US6013516 | US6113901 | US6143297 | US6177078 | US6352694 | US6406696 | US6733743 | US2005003403 | WO2009032661 | EP2050764 | US2011027266 | US8216805 | WO2012135345 | WO2013173820 | WO2015026892 |